Korea Probiotic Supplement Market Demand Outlook 2023-2033

A Complete Study of Probiotic Supplement in Korea from 2023 to 2033

The Korea probiotic supplement industry is projected to expand at a CAGR of 11.6% through 2033. The demand for probiotic supplement in Korea is predicted to overgrow, reaching US$ 241.03 million in 2023.

Growing public awareness of the significance of gut health, as well as increased demand for functional foods and dietary supplement, have all contributed to the industry expansion of probiotic supplement in Korea. The industry size of probiotic supplement in Korea is likely to be worth US$ 722.70 million by 2033.

Key Highlights

The Korean population comprises a significant proportion of the geriatric demographic. Elderly individuals are more vulnerable to health issues caused by gut imbalances. Demand for probiotic supplement is on the surge since it can enhance gut health and reduce the risk of specific problems.
Customers in Korea are increasingly investing in health and wellness products due to their disposable incomes, with probiotic supplement, rich in essential nutrients, driving this demand.
Probiotics are living microorganisms comparable to the helpful bacteria in the digestive tract. People prefer consuming them since many health advantages are associated with them. These include strengthening the immune system, reducing the risk of certain illnesses, and enhancing gastrointestinal health.

Attributes	Key Statistics
Expected Base Year Value (2023)	US$ 241.03 million
Anticipated Forecast Value (2033)	US$ 722.70 million
Estimated Growth (2023 to 2033)	11.6% CAGR

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Consumption Analysis of Probiotic Supplement in Korea

Consumers in South Korea are increasingly prioritizing their food choices due to societal trends toward health and well-being. Probiotic pills have become a crucial part of their health-conscious lifestyle.
The increasing number of scientific studies highlighting the connection between intestinal health and overall well-being has raised consumer awareness in Korea. This emphasized the importance of probiotics for digestive health and immune system support.
The rise in digestive disorders such as irritable bowel syndrome (IBS) and lactose intolerance in Korea has fueled a surge in demand for probiotic supplement. These supplement offer a natural and effective solution to stomach issues.
The probiotic supplement industry has expanded tremendously due to the rising trend of functional foods and dietary supplement for health benefits among Korean consumers.
Companies are releasing a range of probiotic supplement, including capsules, powders, and drinks, to appeal to consumer interests and demographics, and the sector is experiencing a rise in innovation.
The Korean government's support for health and well-being, along with regulatory frameworks for dietary supplement, has aided the growth of the probiotic supplement industry.

Category-wise Insights

Rising Demand for Lactobacillus Supplement in the Korea

Attributes	Details
Bacteria Type	Lactobacillus
Industry Share in 2023	36.3%

Lactobacillus bacteria used in probiotic supplement are expected to grow significantly, accounting for 36.3% of the total in 2023.
Lactobacillus helps to battle with diarrhea, high cholesterol, skin diseases, irritable bowel syndrome, and lung infections.
Several Lactobacillus species featured in probiotic supplement are increasing its popularity in Korea. For instance, Lactobacillus acidophilus regulates the population of dangerous bacteria that might increase in individual’s stomach due to sickness or antibiotics, whereas Lactobacillus fermentum boosts people’s immune system. This helps to keep gastrointestinal and upper respiratory illnesses at bay.
Consumers are becoming more aware of their bodies' health and fitness. As a result, people are spending money on various types of probiotics.

Female Demographic Drives the Demand for Probiotic Supplement in Korea

Attributes	Details
End User	Women
Industry Share in 2023	42.5%

Women are expected to account for about 42.5% of the value of the Korea probiotic supplement industry in 2023.
Women worldwide are susceptible to bacterial infections of the vaginal and urinary tract, and Korea is no exception. If left untreated, these infections can recur and potentially progress to severe neurogenic bladder infections. As a result, people resort to probiotic pills to help them control their symptoms.
Probiotic supplement manufacturers in Korea are actively focusing on women, as research indicates that 'good' bacteria can enhance immunity, aid digestion, and positively impact fertility.

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Competitive Landscape

Industry players have employed various growth strategies to gain a competitive advantage, including capacity expansions, mergers and acquisitions, enhancing their online presence, and introducing new products. Some of the top Korean probiotic supplement firms include Cell Biotech, AceBiome, Amorepacific, Chong Dun Kang, Esther Formula, CJ Cheiljedang, and IIdong Pharmaceutical.

Innovations and creative approaches have benefited the probiotic supplement sector in Korea. Several product introductions in recent years have expanded the industry's client base while intensifying competition within the sector.

Recent Development in the Probiotic Supplement Industry in Korea

Sanofi Consumer Healthcare Korea and AB-BIOTICS announced that they are going to launch Superbiotics Cholesterol in South Korea in June 2023, offering probiotics beyond intestinal health under the Cenovis supplement brand.
Cell Biotech, a Seoul-based probiotic company, launched a pet lactic acid bacteria product in May 2023, targeting South Korea's growing pet demand. The chewable supplement aims to improve internal microbial conditions in animals.
In May 2023, AceBiome, a South Korean probiotic company, prioritized joint health due to the aging population by introducing weight-management probiotic BNRThin.

Key Players Offering Probiotic Supplement in Korea

Cell Biotech
AceBiome
Amorepacific
Chong Dun Kang
Esther Formula
CJ Cheiljedang
IIdong Pharmaceutical

Scope of the Report

Attribute	Details
Estimated Valuation (2023)	US$ 241.03 million
Projected Valuation (2033)	US$ 722.70 million
Anticipated CAGR (2023 to 2033)	11.6% CAGR
Historical Analysis of Probiotic Supplement in Korea	2018 to 2022
Demand Forecast for Probiotic Supplement in Korea	2023 to 2033
Quantitative Units	Revenue in US$ million and CAGR from 2023 to 2033
Report Coverage	Industry Size, Industry Trends, Key Insights for Probiotic Supplement Adoption in Korea, Insights on Global Players and Leading Industry Strategy in Korea, Ecosystem Analysis of Local and Regional Industry.
Key Companies Profiled	Cell Biotech; AceBiome; Amorepacific; Chong Dun Kang; Esther Formula; CJ Cheiljedang; IIdong Pharmaceutical

Key Segment

By Bacteria:

Lactobacillus
Streptococcus
Bifidobacterium

By Form:

Tablet
Capsules
Liquid
Powder Premixes
Gummies/Chewable
Lozenges
Liquid & Gels

By Function:

Immunity & Digestive Health
Urogenital Health
Vaginal Health
Urinary Tract Infections
Pregnancy
Weight Management
By Distribution Channel:
- Hypermarket/ Supermarket
- Specialty Stores
- eCommerce
- Pharmacy Stores

By End User:

Women
Seniors
Kids

By Province:

South Gyeongsang
North Jeolla
South Jeolla
Jeju

Frequently Asked Questions

At What Rate is the Probiotic Supplement Industry Growing in Korea?

The anticipated CAGR for the Korea probiotic supplement industry through 2033 is 11.6%.

How big will the Probiotic Supplement Landscape be in Korea?

Demand for probiotic supplement in Korea is likely to surpass US$ 722.70 million by 2033.

What is the Current Industry Size of Probiotic Supplement in Korea?

In 2023, the industry size for probiotic supplement in Korea is valued at US$ 241.03 million.

Which is the Preferred Bacteria Utilized in Probiotic Supplement in Korea?

Lactobacillus are highly preferred in Korea, with an industry share of 36.3%.

Which is the Key demographic of Probiotic Supplement in Korea?

In Korea, women consumers dominates the probiotic supplement industry with 42.5% industry share.

Table of Content

1. Executive Summary
1.1. Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.5.1. Supply Side Participants and their Roles
3.5.1.1. Producers
3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
3.5.1.3. Wholesalers and Distributors
3.5.2. Value Added and Value Created at Node in the Supply Chain
3.5.3. List of Raw Material Suppliers
3.5.4. List of Existing and Potential Buyer’s
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.7.1. Profit Margin Analysis
3.7.2. Wholesalers and Distributors
3.7.3. Retailers
3.8. PESTLE and Porter’s Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.10. Regional Parent Market Outlook
3.11. Production and Consumption Statistics
3.12. Import and Export Statistics
4. Industry Analysis and Outlook 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) & Volume (Tons) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) & Volume (Tons) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Bacteria
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) & Volume (Tons) Analysis By Bacteria, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) & Volume (Tons) Analysis and Forecast By Bacteria, 2023 to 2033
5.3.1. Lactobacillus
5.3.2. Streptococcus
5.3.3. Bifid bacterium
5.4. Y-o-Y Growth Trend Analysis By Bacteria, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Bacteria, 2023 to 2033
6. Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Form
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) & Volume (Tons) Analysis By Form, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) & Volume (Tons) Analysis and Forecast By Form, 2023 to 2033
6.3.1. Tablet
6.3.2. Capsules
6.3.3. Liquid
6.3.4. Powder Premixes
6.3.5. Gummies/Chewable
6.3.6. Lozenges
6.3.7. Liquid & Gels
6.4. Y-o-Y Growth Trend Analysis By Form, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By Form, 2023 to 2033
7. Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Function
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) & Volume (Tons) Analysis By Function, 2018 to 2022
7.3. Current and Future Market Size Value (US$ Million) & Volume (Tons) Analysis and Forecast By Function, 2023 to 2033
7.3.1. Immunity & Digestive Health
7.3.2. Urogenital Health
7.3.3. Vaginal Health
7.3.4. Urinary Tract Infections
7.3.5. Pregnancy
7.3.6. Weight Management
7.4. Y-o-Y Growth Trend Analysis By Function, 2018 to 2022
7.5. Absolute $ Opportunity Analysis By Function, 2023 to 2033
8. Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Distribution Channel
8.1. Introduction / Key Findings
8.2. Historical Market Size Value (US$ Million) & Volume (Tons) Analysis By Distribution Channel, 2018 to 2022
8.3. Current and Future Market Size Value (US$ Million) & Volume (Tons) Analysis and Forecast By Distribution Channel, 2023 to 2033
8.3.1. Hypermarket/ Supermarket
8.3.2. Specialty Stores
8.3.3. E-Commerce
8.3.4. Pharmacy Stores
8.4. Y-o-Y Growth Trend Analysis By Distribution Channel, 2018 to 2022
8.5. Absolute $ Opportunity Analysis By Distribution Channel, 2023 to 2033
9. Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By End User
9.1. Introduction / Key Findings
9.2. Historical Market Size Value (US$ Million) & Volume (Tons) Analysis By End User, 2018 to 2022
9.3. Current and Future Market Size Value (US$ Million) & Volume (Tons) Analysis and Forecast By End User, 2023 to 2033
9.3.1. Women
9.3.2. Seniors
9.3.3. Seniors
9.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022
9.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033
10. Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Region
10.1. Introduction
10.2. Historical Market Size Value (US$ Million) & Volume (Tons) Analysis By Region, 2018 to 2022
10.3. Current Market Size Value (US$ Million) & Volume (Tons) Analysis and Forecast By Region, 2023 to 2033
10.3.1. South Gyeongsang
10.3.2. North Jeolla
10.3.3. South Jeolla
10.3.4. Jeju
10.3.5. Rest of Korea
10.4. Market Attractiveness Analysis By Region
11. South Gyeongsang Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033
11.1. Historical Market Size Value (US$ Million) & Volume (Tons) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) & Volume (Tons) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Bacteria
11.2.2. By Form
11.2.3. By Function
11.2.4. By Distribution Channel
11.2.5. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Bacteria
11.3.2. By Form
11.3.3. By Function
11.3.4. By Distribution Channel
11.3.5. By End User
11.4. Key Takeaways
12. North Jeolla Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033
12.1. Historical Market Size Value (US$ Million) & Volume (Tons) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) & Volume (Tons) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Bacteria
12.2.2. By Form
12.2.3. By Function
12.2.4. By Distribution Channel
12.2.5. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Bacteria
12.3.2. By Form
12.3.3. By Function
12.3.4. By Distribution Channel
12.3.5. By End User
12.4. Key Takeaways
13. South Jeolla Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033
13.1. Historical Market Size Value (US$ Million) & Volume (Tons) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) & Volume (Tons) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Bacteria
13.2.2. By Form
13.2.3. By Function
13.2.4. By Distribution Channel
13.2.5. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Bacteria
13.3.2. By Form
13.3.3. By Function
13.3.4. By Distribution Channel
13.3.5. By End User
13.4. Key Takeaways
14. Jeju Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033
14.1. Historical Market Size Value (US$ Million) & Volume (Tons) Trend Analysis By Market Taxonomy, 2018 to 2022
14.2. Market Size Value (US$ Million) & Volume (Tons) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Bacteria
14.2.2. By Form
14.2.3. By Function
14.2.4. By Distribution Channel
14.2.5. By End User
14.3. Market Attractiveness Analysis
14.3.1. By Bacteria
14.3.2. By Form
14.3.3. By Function
14.3.4. By Distribution Channel
14.3.5. By End User
14.4. Key Takeaways
15. Rest of Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033
15.1. Historical Market Size Value (US$ Million) & Volume (Tons) Trend Analysis By Market Taxonomy, 2018 to 2022
15.2. Market Size Value (US$ Million) & Volume (Tons) Forecast By Market Taxonomy, 2023 to 2033
15.2.1. By Bacteria
15.2.2. By Form
15.2.3. By Function
15.2.4. By Distribution Channel
15.2.5. By End User
15.3. Market Attractiveness Analysis
15.3.1. By Bacteria
15.3.2. By Form
15.3.3. By Function
15.3.4. By Distribution Channel
15.3.5. By End User
15.4. Key Takeaways
16. Market Structure Analysis
16.1. Competition Dashboard
16.2. Competition Benchmarking
16.3. Market Share Analysis of Top Players
16.3.1. By Regional
16.3.2. By Bacteria
16.3.3. By Form
16.3.4. By Function
16.3.5. By Distribution Channel
16.3.6. By End User
17. Competition Analysis
17.1. Competition Deep Dive
17.1.1. MEDIOGEN
17.1.1.1. Overview
17.1.1.2. Product Portfolio
17.1.1.3. Profitability by Market Segments
17.1.1.4. Sales Footprint
17.1.1.5. Strategy Overview
17.1.1.5.1. Marketing Strategy
17.1.1.5.2. Product Strategy
17.1.1.5.3. Channel Strategy
17.1.2. ESTHER FORMULA
17.1.2.1. Overview
17.1.2.2. Product Portfolio
17.1.2.3. Profitability by Market Segments
17.1.2.4. Sales Footprint
17.1.2.5. Strategy Overview
17.1.2.5.1. Marketing Strategy
17.1.2.5.2. Product Strategy
17.1.2.5.3. Channel Strategy
17.1.3. Jarrow Formulas
17.1.3.1. Overview
17.1.3.2. Product Portfolio
17.1.3.3. Profitability by Market Segments
17.1.3.4. Sales Footprint
17.1.3.5. Strategy Overview
17.1.3.5.1. Marketing Strategy
17.1.3.5.2. Product Strategy
17.1.3.5.3. Channel Strategy
17.1.4. NOVA Probiotics
17.1.4.1. Overview
17.1.4.2. Product Portfolio
17.1.4.3. Profitability by Market Segments
17.1.4.4. Sales Footprint
17.1.4.5. Strategy Overview
17.1.4.5.1. Marketing Strategy
17.1.4.5.2. Product Strategy
17.1.4.5.3. Channel Strategy
17.1.5. Lifeway Foods
17.1.5.1. Overview
17.1.5.2. Product Portfolio
17.1.5.3. Profitability by Market Segments
17.1.5.4. Sales Footprint
17.1.5.5. Strategy Overview
17.1.5.5.1. Marketing Strategy
17.1.5.5.2. Product Strategy
17.1.5.5.3. Channel Strategy
17.1.6. Natural Factors
17.1.6.1. Overview
17.1.6.2. Product Portfolio
17.1.6.3. Profitability by Market Segments
17.1.6.4. Sales Footprint
17.1.6.5. Strategy Overview
17.1.6.5.1. Marketing Strategy
17.1.6.5.2. Product Strategy
17.1.6.5.3. Channel Strategy
17.1.7. Pharma Care Laboratories
17.1.7.1. Overview
17.1.7.2. Product Portfolio
17.1.7.3. Profitability by Market Segments
17.1.7.4. Sales Footprint
17.1.7.5. Strategy Overview
17.1.7.5.1. Marketing Strategy
17.1.7.5.2. Product Strategy
17.1.7.5.3. Channel Strategy
17.1.8. Total Nutrition,
17.1.8.1. Overview
17.1.8.2. Product Portfolio
17.1.8.3. Profitability by Market Segments
17.1.8.4. Sales Footprint
17.1.8.5. Strategy Overview
17.1.8.5.1. Marketing Strategy
17.1.8.5.2. Product Strategy
17.1.8.5.3. Channel Strategy
17.1.9. Church & Dwight
17.1.9.1. Overview
17.1.9.2. Product Portfolio
17.1.9.3. Profitability by Market Segments
17.1.9.4. Sales Footprint
17.1.9.5. Strategy Overview
17.1.9.5.1. Marketing Strategy
17.1.9.5.2. Product Strategy
17.1.9.5.3. Channel Strategy
17.1.10. Goerlich Pharma
17.1.10.1. Overview
17.1.10.2. Product Portfolio
17.1.10.3. Profitability by Market Segments
17.1.10.4. Sales Footprint
17.1.10.5. Strategy Overview
17.1.10.5.1. Marketing Strategy
17.1.10.5.2. Product Strategy
17.1.10.5.3. Channel Strategy
18. Assumptions & Acronyms Used
19. Research Methodology

Demand and Trend Analysis of Probiotic Supplement in Korea

Demand Forecast for Probiotic Supplement in Korea, by Streptococcus, Bifidobacterium, and Lactobacillus, 2023 to 2033